Cresud S.A.C.I.F. y A. (NASDAQ:CRESY) was downgraded by stock analysts at TheStreet from a “hold” rating to a “sell” rating in a report issued on Wednesday. Cresud S.A.C.I.F. y A. (ADR) (NASDAQ:CRESY) in last trading activity advanced 7.73% to close at $10.04. Company weekly performance is -1.18% while its quarterly performance stands at -12.08%. Cresud S.A.C.I.F. y A. (ADR) (NASDAQ:CRESY) is -29.28% away from its 52 week high.
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) CEO Jeffrey M. Leiden sold 50,017 shares of the stock on the open market in a transaction dated Monday, December 15th. The stock was sold at an average price of $114.97, for a total value of $5,750,454.49. Following the completion of the transaction, the chief executive officer now directly owns 217,677 shares of the company’s stock, valued at approximately $25,026,325.On last trading day Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) advanced 5.27% to close at $117.74. Its volatility for the week is 4.47% while volatility for the month is 3.50%. VRTX’s sales growth for past 5 years was 47.20% and its EPS growth for past 5 years was 9.50%. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) monthly performance is 6.03%.
Thompson Creek Metals Company Inc. (NYSE:TC) on 10 December announced that it and its joint venture partner, Sojitz Moly Resources, Inc. (“Sojitz”), have agreed to place the Endako molybdenum mine on temporary suspension effective December 31, 2014, due to continued weakness in the molybdenum market. Thompson Creek holds a 75% interest in the Endako Mine, and Sojitz holds the remaining 25% interest.On last trading day Thompson Creek Metals Company Inc. (NYSE:TC) advanced 3.05% to close at $1.69. Its volatility for the week is 7.68% while volatility for the month is 7.06%. TC’s sales growth for past 5 years was -15.60% and its EPS growth for past 5 years was -24.30%. Thompson Creek Metals Company Inc. (NYSE:TC) monthly performance is -14.65%.
Banco Bradesco SA (NYSE:BBDO) was the target of a significant decline in short interest during the month of November. As of November 14th, there was short interest totalling 6,906,719 shares, a decline of 42.5% from the October 31st total of 12,011,369 shares, AnalystRatingsNetwork.com reports. Banco Bradesco S.A. (NYSE:BBDO) stock closed at $13.20.
VIVUS, Inc. (NASDAQ:VVUS) on 15 December announced that Qsymia is the sole anti-obesity agent listed on the CVS/Caremark Performance Drug List, or PDL. Preferred brand-name medicines are listed on the PDL to help identify products that are clinically appropriate and cost-effective as defined by CVS/Caremark. On Thursday shares of VIVUS Inc. (NASDAQ:VVUS) closed at $3.17. Company’s sales growth for last 5 years was -0.60% and EPS growth for next 5 years is recorded as 16.50%.